Abbott reported an increase in nutritional sales despite ongoing softness in the US, its largest market, and negative currency effect.
In a fourth-quarter update today (29 January), the company said total nutrition sales in the three months climbed 6% to US$1.8bn.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Gains were propelled by expanding sales at Abbott’s overseas nutrition businesses, where revenue on a constant currency basis climbed 19.3%. However, international sales on a reported basis rose at a slower pace of 14.3% in the quarter. In the US, Abbott’s single largest market for nutrition products, sales were down 5.1% to $687m.
On a group-wide basis the pharmaceuticals giant said total sales rose 5.6%.
